• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immune responses to twice-annual influenza vaccination in older adults in Hong Kong

tetano

Editor, Senior Moderator
Clin Infect Dis. 2017 Oct 21. doi: 10.1093/cid/cix900. [Epub ahead of print]
[h=1]Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.[/h] Tam YH[SUP]1[/SUP], Valkenburg SA[SUP]2[/SUP], Perera RAPM[SUP]1,[/SUP][SUP]3[/SUP], Wong JHF[SUP]1[/SUP], Fang VJ[SUP]1[/SUP], Ng TWY[SUP]1[/SUP], Kwong ASK[SUP]4[/SUP], Tsui WWS[SUP]4[/SUP], Ip DKM[SUP]1[/SUP], Poon LLM[SUP]1,[/SUP][SUP]3[/SUP], Chau CKV[SUP]4[/SUP], Barr IG[SUP]5,[/SUP][SUP]6[/SUP], Peiris JSM[SUP]1,[/SUP][SUP]3[/SUP], Cowling BJ[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] Many health authorities recommend influenza vaccination of older adults to reduce disease burden. We hypothesized that in tropical and subtropical areas with more prolonged influenza seasons, twice-annual influenza vaccination might provide older adults with improved immunity against influenza.
[h=4]Methods:[/h] In 2014/15, Hong Kong experienced a substantial A(H3N2) winter epidemic with a mismatched vaccine. Local authorities procured and administered to older adults the 2015 southern hemisphere influenza vaccine which included an updated and matching A/Switzerland/9715293/2013(H3N2) strain. We compared immune parameters in pre- and post-vaccination sera from older adults ≥75 years of age who received one versus two influenza vaccines per year.
[h=4]Results:[/h] We enrolled 978 older adults with 470 vaccinations for summer 2015 and 827 vaccinations for winter 2015/16. Recipients of southern hemisphere vaccination had higher geometric mean titers (GMTs) by the hemagglutination inhibition assay against all three vaccine strains. When receiving influenza vaccination for the subsequent winter, the southern hemisphere vaccine recipients had higher pre-vaccination GMTs but lower post-vaccination GMTs, compared to those who had not received the southern hemisphere vaccine. Furthermore, cellular immunity was impacted by bi-annual vaccination, with reduced influenza-specific CD4 T cell responses in the second season of vaccination.
[h=4]Conclusions:[/h] We observed some reductions in immune responses in the twice-annual vaccination group compared to once-annual vaccination group, in the context of unchanging vaccine strains, while protection was likely to have been improved during the summer and autumn for the twice-annual vaccination group due to the continued circulation of the A/Switzerland/9715293/2013(H3N2) virus.


PMID: 29069368 DOI: 10.1093/cid/cix900
 
Back
Top Bottom